Association Between Carotid Plaque Length and Cardiovascular Events

December 16, 2021 updated by: Pan Li, Changhai Hospital
This multicenter study involved 5 hospitals (Changhai Hospital; Yueyang Hospital of Shanghai University of Traditional Chinese Medicine; Gongli Hospital; Putuo Hospital of Shanghai University of Traditional Chinese Medicine; No. 904 Hospital of the PLA Joint Logistics Support Force Wuxi). The study enrolled 3637 patients with coronary atherosclerosis who were confirmed by coronary angiography from January 2017 through December 2018.

Study Overview

Status

Active, not recruiting

Conditions

Detailed Description

Patients with coronary atherosclerosis who were confirmed by coronary angiography were eligible for the study. Carotid ultrasonography was simultaneously performed, and carotid intima-media thickness (IMT), maximum thickness and length of all plaques were measured.

Study Type

Observational

Enrollment (Actual)

3637

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Jiangsu
      • Wuxi, Jiangsu, China, 214000
        • No. 904 Hospital of the PLA Joint Logistics Support Force
    • Shanghai
      • Shanghai, Shanghai, China, 200000
        • Changhai Hospital
      • Shanghai, Shanghai, China, 200000
        • Gongli Hospital
      • Shanghai, Shanghai, China, 200000
        • Putuo Hospital
      • Shanghai, Shanghai, China, 200000
        • Yueyang Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients hospitalized for coronary angiography and underwent carotid ultrasonography simultaneously

Description

Inclusion Criteria:

  • Patients≥18 years old, those who underwent carotid ultrasonography and first coronary angiography simultaneously.

Exclusion Criteria:

  • Patients with known coronary artery disease, previous coronary or carotid revascularization, missing carotid ultrasound or coronary angiography results.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Carotid plaque length
Patients underwent coronary angiography and carotid ultrasonography simultaneously

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Major adverse cardiovascular events
Time Frame: 3 years
A composite of cardiovascular death, myocardial infarction, and stroke
3 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incident cardiovascular events
Time Frame: 3 years
A composite of cardiovascular death, myocardial infarction, stroke, and unplanned coronary artery revascularization
3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Changhai Hospital

Collaborators

Putuo Hospital, Shanghai University of Traditional Chinese Medicine
No. 904 Hospital of the PLA Joint Logistics Support Force
Gongli Hospital
Yueyang Hospital, Shanghai University of Traditional Chinese medicine

Investigators

  • Principal Investigator: Pan Li, PhD, Changhai Hospital
  • Study Director: Jian Na, MD, Putuo Hospital
  • Study Director: Liang Chen, MD, No. 904 Hospital of the PLA Joint Logistics Support Force
  • Study Director: Wei Zhang, MD, Gongli Hospital
  • Study Director: Yawei Yang, MD, Yueyang Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

June 30, 2021

Study Completion (Anticipated)

December 30, 2030

Study Registration Dates

First Submitted

December 3, 2021

First Submitted That Met QC Criteria

December 3, 2021

First Posted (Actual)

December 16, 2021

Study Record Updates

Last Update Posted (Actual)

January 6, 2022

Last Update Submitted That Met QC Criteria

December 16, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CPL-2017

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coronary Arteriosclerosis

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe